Vanderbilt - Ingram Cancer Center — Nashville, Tennessee

Vanderbilt - Ingram Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Vanderbilt - Ingram Cancer Center has participated in 20 clinical trials with 10 currently active.

Therapeutic areas: AML/MDS, Rhabdomyosarcoma, Advanced Upper Gastrointestinal Tract Adenocarcinoma.

Sponsors: Mana Therapeutics, H. Lee Moffitt Cancer Center and Research Institute, Arcus Biosciences, Inc..

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt - Ingram Cancer Center?

Vanderbilt - Ingram Cancer Center has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt - Ingram Cancer Center conducted?

Vanderbilt - Ingram Cancer Center has 20 clinical trials on record, with 10 currently active. Their work covers AML/MDS, Rhabdomyosarcoma, Advanced Upper Gastrointestinal Tract Adenocarcinoma.

Is Vanderbilt - Ingram Cancer Center accredited by Crixeo Health?

Yes — Vanderbilt - Ingram Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Vanderbilt - Ingram Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.